| 607948 |
BMJ OPEN |
Optimisation, validation and field applicability of a 13C-sucrose breath test to assess intestinal function in environmental enteropathy among children in resource poor settings: study protocol for a prospective study in Bangladesh, India, Kenya, Jamaica, |
2020-11-01 |
10.1136/bmjopen-2019-035841 |
Lee Gwenyth O, Schillinger Robert, Shivakumar Nirupama, Whyte Sherine, Huq Sayeeda, Ochieng Konyole Silvenus, Chileshe Justin, Paredes-Olortegui Maribel, Owino Victor, Yazbeck Roger, Kosek Margaret N, Kelly Paul, Morrison Douglas |
| 607947 |
BIOMOLECULES & THERAPEUTICS |
Crotamiton, an Anti-Scabies Agent, Suppresses Histamine- and Chloroquine-Induced Itch Pathways in Sensory Neurons and Alleviates Scratching in Mice |
2020-11-01 |
10.4062/biomolther.2020.063 |
Choi, Da-Som, Ji, Yeounjung, Jang, Yongwoo, Lee, Wook-Joo, Shim, Won-Sik |
| 607946 |
CANCER MANAGEMENT AND RESEARCH |
Clinical Features and Short-Term Outcomes in COVID-19-Infected Patients with Cancer |
2020-11-01 |
10.2147/cmar.s279564 |
Wang Yong, Shan Ben-Jie, Shen Xia-Bo, Zheng Chang-Cheng, Wang Jin-Quan, Li Gui-Ling, Pan Yue-Yin |
| 607945 |
大韓保健硏究 |
방사선을 주제로 한 항공 승무원들의 대화빈도와 불안감의 관계 |
2020-11-01 |
10.22900/kphr.2020.46.4.007 |
신형호, 박상신 |
| 607944 |
NEURO-ONCOLOGY |
EPCO-13. GENOME-WIDE ASSOCIATION STUDY IN INDIVIDUALS OF ASHKENAZI JEWISH ANCESTRY IDENTIFIES NOVEL RISK LOCI FOR GLIOMA | EPCO-13. GENOME-WIDE ASSOCIATION STUDY IN INDIVIDUALS OF ASHKENAZI JEWISH ANCESTRY IDENTIFIES NOVEL RISK LOCI FOR GLIOMA |
2020-11-01 |
10.1093/neuonc/noaa215.292 |
Ostrom Quinn, Byun Jinyoung, Amos Christopher, Claus Elizabeth, Bondy Melissa |
| 607943 |
NEURO-ONCOLOGY |
DDRE-16. SYNERGISTIC TUMOR SUPPRESSION FROM COMBINATION OF ONC201 AND EPIGENETIC MODULATORS EZH2 OR HDAC INHIBITOR PROVIDES A NOVEL TREATMENT STRATEGY FOR GBM AND DMG | DDRE-16. SYNERGISTIC TUMOR SUPPRESSION FROM COMBINATION OF ONC201 AND EPIGENETIC MODUL |
2020-11-01 |
10.1093/neuonc/noaa215.261 |
Zhang Yiqun, Zhou Lanlan, Howard Safran, Seyhan Attila, El-Deiry Wafik |
| 607942 |
NEURO-ONCOLOGY |
CTNI-79. PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA | CTNI-79. PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA |
2020-11-01 |
10.1093/neuonc/noaa215.245 |
Kebir Sied, Lazaridis Lazaros, Schmidt Teresa, Oster Christoph, Pierscianek Daniela, Guberina Nika, Kleinschnitz Christoph, Proescholdt Martin, Hau Peter, Grosu Anca-Ligia, Sure Ulrich, Scheffler Björn, Stuschke Martin, Glas Martin |
| 607941 |
NEURO-ONCOLOGY |
NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY | NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY |
2020-11-01 |
10.1093/neuonc/noaa215.529 |
Yuen Carlen, Riedell Peter, Artz Andrew, Kosuri Satyajit, Kelly Thomas, Wu Shasha, Reder Anthony, Rezania Kourosh, Soliven Betty, Xie Tao, Mastrianni James, Park Deric, Klejch Wesley, Ali Saad, Bishop Michael |
| 607940 |
RADIOTHERAPY AND ONCOLOGY : JOURNAL OF THE EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY |
An especially high rate of radiation pneumonitis observed in patients treated with thoracic radiotherapy and simultaneous osimertinib |
2020-11-01 |
10.1016/j.radonc.2020.07.051 |
Jia Wenxiao, Guo Hongbo, Jing Wang, Jing Xuquan, Li Ji, Wang Min, Yu Jinming, Zhu Hui |
| 607939 |
GYNECOLOGIC ONCOLOGY REPORTS |
Response to re-challenge of a MEK inhibitor in a patient with recurrent low-grade serous carcinoma of the peritoneum |
2020-11-01 |
10.1016/j.gore.2020.100670 |
Gershenson David M., Bhosale Priya, Grisham Rachel N. |
